Wacker Chemie AG (OTCPK:WKCMF)
$ 110 3.8 (3.58%) Market Cap: 5.45 Bil Enterprise Value: 5.55 Bil PE Ratio: 16.08 PB Ratio: 1.14 GF Score: 83/100

Wacker Chemie AG CMD Series: Biosolutions & R&D Transcript

Jun 24, 2021 / 08:00AM GMT
Release Date Price: $162 (+7.00%)
Joerg Hoffmann
Wacker Chemie AG - Head of IR

Welcome, everybody, to the Wacker Chemie AG Virtual Capital Market Day on R&D and BioSolutions. Before we begin, please allow me to point you to safe harbor statement, which you'll find at the slide deck's beginning. You will also find a slido.com link there that enables you to ask questions during the Q&A session at the end of today's presentation.

Today's presenters are Chris Hartel, our CEO; Tobias Ohler, our CFO; Susanne Leonhartsberger, President of BioSolutions; and Christoph Kowitz, Head of R&D. The presentation is available to download on our web page under the caption Investor Relations. Chris?

Christian Hartel
Wacker Chemie AG - CEO, President & Member of Executive Board

Thank you, Joerg. Ladies and gentlemen, welcome to the third edition of our Virtual Capital Market Day series. In June and December of last year, we first covered a strategy update and our main chemical segments. Today, we will speak about key growth progress beyond silicones and polymers. Our next edition in Q4

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot